Drug Trial Radar · NCT02703896
Prophylaxis for Aspiration of Gastric Contents.
Last checked: Nov 19, 2026Latest source record: Mar 9, 2016 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,920
Actual
Start
Jan 2012
Primary completion
Jan 2012
Study completion Dec 2015
Sponsor
- Lead sponsor
- King Saud UniversityAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Mar 9, 2016
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Prevention
- Who can join
- All sexes, from 15 years, up to 70 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
Effect of orally administered two equal and consecutive doses of proton pump inhibitors, omeprazole, lansoprazole, esomeprazole , rabeprazole and pantoprazole and Histamine 2 receptor antagonists cimetidine, ranitidine,famotidine,nizatidine and lafutidine without and with a prokinetic agents domperidone, metoclopramide and erythromycin on intragastric pH, volume and bile refluxate.
Conditions
- Pulmonary Aspiration of Gastric Contents
Interventions
Drug either PPIS or H2RA and prokineticsDrug
Drug intervention ( dose unit mg) Two oral doses 8:00 p.m. and 6:00 a.m. (n=60) total 10 groups 1. Group C (placebo),Group L (lansoprazole15 ), Group LD (Lansoprazole 15 +domperidone 10 ) 2. Group C ,R (rabeprazole 10), RM (rabeprazole 10 + metoclopramide 10) 3. Group C , E (esomeprazole 20 ), and EM (esomeprazole 20 + metoclopramide 10) 4. Group C, P (pantoprazole 20), and PD (pantoprazole 20 + domperidone 10 mg) 5. Group C, O (omeprazole 20), OD (omeprazole 20 + domepridone 10), OM (omeprazole 20 + metoclopramide 10) 6. Group C,T (cimetidine 200), TD (cimetidine 200 + domperidone 10) 7. Group C , Z (ranitidine 150), ZD (ranitidine 150 + domperidone 10) 8. Group C , N (nizatidine 150),NM (nizatidine 150 + metoclopramide 10) 9. Group C, F (famotidine 20 mg), and FM (famotidine 20 mg + metoclopramide 10) 10. Group C,S (lafutidine 10), SD (lafutidine 10 + domperidone 10), and Group SM (lafutidine 10 + metoclopramide 10)
orogastric intubationProcedure
OGT insertion:Insertion of orogastric tube(through an endotracheal tube placed in the upper esophagus) into the stomach after general anaesthesia.
Primary outcomes
What the sponsor says the trial is designed to measure.
- pH of gastric contentsTime frame: Immediate after induction of general anaesthesia
Locations
No sites are listed on the registry yet.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.